CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- 4 Planned sale President and CEO sold 11,732 shares at $3.41 ($40,006)
- 4 Open-market sale COO & CBO sold 4,569 shares at $3.85 ($17,591)
- 4 Open-market sale President and CEO sold 12,192 shares at $3.78 ($46,086)
- 4 Open-market sale Chief Scientific Officer sold 3,525 shares at $3.85 ($13,571)
- 4 Grant or award Chief Medical Officer acquired 45,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 33,000 shares (grant or award)
- 4 Grant or award COO & CBO acquired 45,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 86,250 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 32,250 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Financial Officer sold 7,666 shares at $4.78 ($36,643)
- 4 Open-market sale Chief Medical Officer sold 19,000 shares at $3.73 ($70,870)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 16 · 312 filings